Anavex Life Sciences Corp... (AVXL)
NASDAQ: AVXL
· Real-Time Price · USD
9.30
-0.06 (-0.64%)
At close: Sep 05, 2025, 10:08 AM
-0.64% (1D)
| Bid | 6.71 |
| Market Cap | 798.81M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -34.93M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -16.61 |
| Forward PE | 4.01 |
| Analyst | Buy |
| Ask | 9.7 |
| Volume | 70,676 |
| Avg. Volume (20D) | 1,026,380 |
| Open | 9.45 |
| Previous Close | 9.36 |
| Day's Range | 9.30 - 9.47 |
| 52-Week Range | 4.93 - 14.44 |
| Beta | 0.80 |
About AVXL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AVXL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AVXL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+8.21%
Anavex Life Sciences shares are trading higher aft...
Unlock content with
Pro Subscription
8 months ago
+29.55%
Anavex Life Sciences shares are trading higher after the company announced better-than-expected Q4 financial results.
3 weeks ago · seekingalpha.com
Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call TranscriptAnavex Life Sciences Corp. (NASDAQ:AVXL ) Q3 2025 Earnings Conference Call August 12, 2025 8:00 AM ET Company Participants Christopher U. Missling - President, CEO, Secretary & Director Clint Tomlinso...
